- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
- Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
- Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
- Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
- Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
More ▼
Key statistics
On Wednesday, Twist Bioscience Corp (TWST:NSQ) closed at 30.75, -28.84% below its 52-week high of 43.21, set on Feb 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.84 |
---|---|
High | 31.90 |
Low | 30.28 |
Bid | 27.49 |
Offer | 31.68 |
Previous close | 31.50 |
Average volume | 957.46k |
---|---|
Shares outstanding | 57.82m |
Free float | 56.79m |
P/E (TTM) | -- |
Market cap | 1.82bn USD |
EPS (TTM) | -3.60 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 21:00 BST.
More ▼